Acute Porphyria Drugs

D07BB03 - Triamcinolone and Antiseptics

Probably not porphyrinogenic
PNP

Rationale
Several references stating non porphyrinogenicity of glucocorticoids. No data on absorption or metabolism of halquinol. Probably insignificant systemic exposure when used in minor quantities.
Chemical description
Creme used in infected dermatoses. Moderately strong glucocorticoid 0.1% combined with the chemotherapeutic halciol (cloxiquine) 0.75% which is a mixture of chlorohydroxyquinoline derivatives with broad action spectrum, including fungal infections. Glucocorticoid: South African list: use Kalman, Bonkovsky: believed to be safe The Merck Manual: use Moore MR, Hift RJ: Drugs in acute porphyria. Cell Mol Biol 43:89, 1997: safe Tschudy DP, Lamon JM: Porphyrin metabolism and the Porphyrias in Bondy BK, Rosenberg LE (eds): Duncan’s Diseases of Metabolism, Philadelphia, WB Saunders 1980, p 939.: safe
Similar drugs
Explore alternative drugs in similar therapeutic classes D07B / D07BB or go back.
References
# Citation details PubMed ID
1. Management of acute attacks in the porphyrias.
Kalman DR, Bonkovsky HL. Clin Dermatol. 1998; 16(2):299-306.
9554242
2. Drugs in the acute porphyrias--toxicogenetic diseases.
Moore MR, Hift RJ. Cell Mol Biol (Noisy-le-grand). 1997 Feb; 43(1):89-94.
9074793
Other sources
3. Porphyrin metabolism and the Porphyrias [Book Chapter]
Tschudy DP, Lamon JM Bondy BK, Rosenberg LE (eds): Duncan's Diseases of Metabolism, Philadelphia, WB Saunders. 1980.
Tradenames

Alkcema Kenacutan Triamcinolon
In cooperation with Ipnet
© Napos 2026
An unhandled error has occurred. Reload 🗙